Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency‐associated lung disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Alpha 1 Antitrypsin Augmentation Therapy for Alpha 1 Antitrypsin Deficiency‐associated Lung Disease." Cochrane Abstracts Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440710/all/Alpha_1_antitrypsin_augmentation_therapy_for_alpha_1_antitrypsin_deficiency‐associated_lung_disease.
Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency‐associated lung disease. Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440710/all/Alpha_1_antitrypsin_augmentation_therapy_for_alpha_1_antitrypsin_deficiency‐associated_lung_disease. Accessed October 5, 2026.
Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency‐associated lung disease. (2026). In Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440710/all/Alpha_1_antitrypsin_augmentation_therapy_for_alpha_1_antitrypsin_deficiency‐associated_lung_disease
Alpha 1 Antitrypsin Augmentation Therapy for Alpha 1 Antitrypsin Deficiency‐associated Lung Disease [Internet]. In: Cochrane Abstracts Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 October 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440710/all/Alpha_1_antitrypsin_augmentation_therapy_for_alpha_1_antitrypsin_deficiency‐associated_lung_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Alpha 1 antitrypsin augmentation therapy for alpha 1 antitrypsin deficiency‐associated lung disease
ID - 440710
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440710/all/Alpha_1_antitrypsin_augmentation_therapy_for_alpha_1_antitrypsin_deficiency‐associated_lung_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

